Calcium and vitamin D supplement

Our large practice urology group has partnered with theralogix, a vitamin company to offer patients products that have been shown in study to help with various conditions.

Prosteon is a bone health supplement for men undergoing Androgen Deprivation Therapy (hormone therapy), or for anyone looking to support their bone health.

It can be ordered through:

Prosteon Bone Health Supplement (90 day supply)

My PRC number for a discount is: 58143

TheraCran One Cranberry Capsules

Our large practice urology group has partnered with theralogix, a vitamin company to offer patients products that have been shown in study to help with various conditions.

TheraCran One Cranberry Capsules is a high-potency cranberry extract with 36 mg of proanthocyanidins (PACs) per capsule, to promote normal urinary tract health.

You can find more information and ordered it through:

TheraCran One Cranberry Capsules

My PRC number for a discount is: 58143

Prostate PQ for urinary health

Our large practice urology group has partnered with theralogix, a vitamin company to offer patients products that have been shown in study to help with various conditions.

Prostate PQ is a rye grass flower pollen extract and quercetin supplement formulated to support prostate health and normal urinary tract function in men.

It can be ordered through:

Prostate PQ pollen extract supplement

My PRC number for a discount is: 58143

 

Prostate Cancer Risk Lower in Men Who Ejaculate More – Renal and Urology News

The protective effect of frequent intercourse is strongest for low-risk prostate cancer.

An ejaculation frequency of 21 or more times per month at age 20–29 years and 40–49 years is associated with a significant 19% and 22% decreased risk of a PCa diagnosis, respectively, compared with a frequency of 4–7 times per month in adjusted analyses, Jennifer R. Rider, MD, of the Boston University School of Public Health, and colleagues reported. In addition, results showed that ejaculation frequency at age 20–29 years was significantly associated with intermediate-risk PCa. Men in this age group who had 13 or more ejaculations per month experienced a significant 27% reduction in the risk of a diagnosis of intermediate-risk PCa compared with those who had 4–7 ejaculations per month. Ejaculation frequency was not significantly associated with a diagnosis of high-risk PCa or regional/distant metastases, according to the investigators.

Source: Prostate Cancer Risk Lower in Men Who Ejaculate More – Renal and Urology News

Men often ask me about the effects of sexual activity on prostate cancer. This study shows that more frequent relations help prevent prostate cancer.  The amount of activity needed to have this benefit seems high to me.  Being active more than 2 of 3 days is much more than most men are currently experiencing.

I will need to add this to the list of things I tell men about how to stay healthy.

Latest Dietary Advice for Prostate Cancer – Renal and Urology News

A range of foods, nutrients, and dietary patterns are being studied for prostate cancer prevention or treatment, according to a 2015 research review.

Source: Latest Dietary Advice for Prostate Cancer – Renal and Urology News

While the ideal diet prescription has yet to be determined, the investigators suggest counseling men with these tips, in line with emerging research and a heart healthy diet:

  • Increase fruits and vegetables.
  • Replace refined carbohydrates with whole grains.
  • Reduce total and saturated fat intake.
  • Avoid overcooked meats (such as charred barbecue).
  • Consume fewer calories (by reducing carbohydrates, for example) to achieve a healthy body weight.

Men often ask about dietary changes if they have prostate cancer.  I have been telling them for years to follow a heart healthy diet, which also will help with their prostate cancer.

An interview with MD Advisor

I recently gave an interview to the MD Advisor. We discussed some of the recent safety concerns with robotic surgery and the daVinci robot.

Some of the important points that we discussed are:

Robotic surgery is performed by a surgeon and is not automated.
Experienced surgeons have less complications that inexperienced surgeons.
Robotic surgery magnification can lead to a more precise surgery, but the magnification will lead to instruments not being in the surgeons filed of view which is similar to laparoscopy.

You can view the article on page 11 of the Fall issue of MD Advisor.

LUGPA position aims to clarify prostate cancer screening | Urology Times

In an attempt to clarify what it calls conflicting guideline statements on prostate cancer screening from various organizations, the Large Urology Group Practice Association (LUGPA) has issued its own position on the use of the PSA test as a screening tool.

“Unfortunately, these conflicting statements have resulted in confusion amongst both our patients and fellow physicians,” said Deepak A. Kapoor, MD, president of LUGPA. “It should be made clear that a PSA test is simply a tool that facilitates informed decision making; it is neither a commitment to have a biopsy nor an obligation to receive treatment should prostate cancer be detected.”

According to a LUGPA press release, after careful evaluation of previously published guidelines and thorough review of recent statements from the European Association of Urology and the Prostate Cancer World Congress, the LUGPA Board of Directors, in consultation with thought leaders in the diagnosis of prostate cancer, unanimously adopted the following official position on PSA screening:

Risks of prostate cancer screening must be uncoupled from risks of prostate cancer detection and treatment.

PSA testing facilitates the early detection of prostate cancer, which results in a reduced risk of being diagnosed with or developing locally advanced and/or metastatic prostate cancer, and a reduction in prostate cancer-specific mortality.

A baseline serum PSA level should be obtained in men in their 40s who have made an informed decision to pursue early detection of prostate cancer.

Intervals for an individual’s prostate cancer screening should be adapted to: baseline PSA, prostate cancer risk factors (including African-American heritage and a family history of prostate cancer), and the potentially short preclinical timeline of aggressive cancers.

PSA screening should be offered to men with a life expectancy of greater than or equal to 10 years, regardless of age.

PSA testing should not be considered on its own, but rather as part of a multivariable approach to early prostate cancer detection.

via LUGPA position aims to clarify prostate cancer screening | Urology Times.

 

This is the best recommendation I have seen from any medical entity to help diagnose prostate cancer for men whose life has a high chance of being impacted by the disease.

Prostate cancer screening event at Overlook Medical Center on October 3, 2013.

ONC-1498-13ProstateCancerScreening

I am participating in a prostate cancer screening event for men over 50 years old that would like to be screened for prostate cancer. Men will have a PSA blood draw and a digital rectal examination. The target audience is for men not under the care of a physician currently.

The event will be held in the hospital from 6 to 9pm. Please call 1-800-247-9580 for pre-registration.

1 2 3 7

Search

+